Publications by authors named "Stephen R Goding"

Claim this Profile
P
PD-L1-Independent Mechanisms Control the Resistance of Melanoma to CD4 T Cell Adoptive Immunotherapy.
Stephen R Goding, Kyle A Wilson, Carolyn Rosinsky, Paul Andrew Antony

J Immunol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
17-AAG inhibits vemurafenib-associated MAP kinase activation and is synergistic with cellular immunotherapy in a murine melanoma model.
Sandeep S Joshi, Shunlin Jiang, Emmanual Unni, Stephen R Goding, Tao Fan

PLoS One· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adoptive transfer of natural killer cells promotes the anti-tumor efficacy of T cells.
Stephen R Goding, Shaohong Yu, Lisa M Bailey, Michael T Lotze, Per H Basse

Clin Immunol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depletion of B220NK1.1 cells enhances the rejection of established melanoma by tumor-specific CD4 T cells.
Kyle A Wilson, Stephen R Goding, Harold R Neely, Kristina M Harris, Paul Andrew Antony

Oncoimmunology· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Restoring immune function of tumor-specific CD4+ T cells during recurrence of melanoma.
Stephen R Goding, Kyle A Wilson, Ying Xie, Kristina M Harris, Aparna Baxi

J Immunol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytokine gene therapy using adenovirally transduced, tumor-seeking activated natural killer cells.
Stephen R Goding, Qin Yang, Kristina B Knudsen, Douglas M Potter, Per H Basse

Hum Gene Ther· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis